Top Markets
Coin of the day
Molecular Pharmacology (USA), Ltd. Molecular Pharmacology (USA), Ltd.

Molecular Pharmacology (USA), Ltd.

MLPH
Classement en actions #39112
As a development-stage company, Molecular Pharmacology (USA) Limited (MLPH) is... As a development-stage company, Molecular Pharmacology (USA) Limited (MLPH) is dedicated to the creation and market introduction of solutions for pain and inflammation, with a primary focus on the Australian and United States markets. Through its subsidiary, Molecular Pharmacology Pty. Ltd., it is advancing an analgesic and anti-inflammatory molecule called Tripeptofen, designed to alleviate common daily pain. These products are offered in diverse dosage forms, formulations, and packaging options to suit various needs. MLPH's marketing strategy involves leveraging pharmaceutical distributors and forging collaborative partnerships with companies in the United States and Europe. Additionally, the company maintains an agreement with Dermatology Development Corporation to jointly develop and market a suite of therapeutic, cosmetic, and cosmeceutical items derived from the ThermaLIFE product line and its core active component. Headquartered in Perth, Australia, Molecular Pharmacology (USA) Limited operates as a subsidiary of PharmaNet Group Limited.
Prix de l'action
$0.0322
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$643.71K
Changement (1 jour)
0.00%
Changement (1 an)
544.00%
Pays
AU
Échange Molecular Pharmacology (USA), Ltd. (MLPH)

Catégorie

Historique du prix de l'action pour Molecular Pharmacology (USA), Ltd. (MLPH)
Prix de clôture le plus élevé : $0.03 le 2026-08-01

Prix de clôture le plus bas : $0.47 le 2009-07-01
Historique du prix de l'action de Molecular Pharmacology (USA), Ltd. de 2009 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 57.97%
2025 300.00%
2024 -86.58%
2023 27.20%
2022 485.71%
2021 -95.90%
2020 31.25%
2019 -32.31%
2018 100.97%
2017 14.79%
2016 -83.06%
2015 -16.84%
2014 -47.72%
2013 50.34%
2012 720.91%
2011 -87.47%
2010 -59.86%
2009 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$517.18 32.51%
US
$857.76 31.47%
NL
$728.05 6.60%
CH
$1.07K -6.40%
KR
$254.79 12.56%
BE